# deferasirox

NDC: 70710-1276
Generic name: deferasirox
Labeler / Manufacturer: Zydus Pharmaceuticals USA Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20200616

FDA application: ANDA211383

## Active ingredients

- DEFERASIROX: 180 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"70710-1276"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=70710-1276
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4af5bc9e-3e09-4dfd-8cc8-7677953c9c7c